Inspire Medical Systems, Inc. 2026 Q1 - Results - Earnings Call Presentation
JP Morgan Maintains Neutral on Inspire Medical Systems, Lowers Price Target to $54
Piper Sandler Downgrades Inspire Medical Systems to Neutral, Lowers Price Target to $55
RBC Capital Maintains Sector Perform on Inspire Medical Systems, Lowers Price Target to $45
Truist Securities Maintains Hold on Inspire Medical Systems, Lowers Price Target to $50
Evercore ISI Group Maintains Outperform on Inspire Medical Systems, Lowers Price Target to $55
Wells Fargo Maintains Equal-Weight on Inspire Medical Systems, Lowers Price Target to $56
Loading...